Federal appeals court judges on Friday questioned whether four major insulin manufacturers could have imposed similar 340B contract pharmacy restrictions [...] …
Category: Federal
A key national hospital advocacy group recently urged the Trump administration to modify the retrospective payment process under the Inflation [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A new bipartisan U.S. Senate proposal, backed by a key lawmaker involved in 340B policy, aims to lower the cost [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The U.S. Department of Health and Human Services (HHS) plans to release guidance within 30 days on 340B rebate models [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
News Alert
Trump’s FY 2026 Budget Blueprint Includes $33 Billion in HHS Cuts, No Details on 340B Plans
President Donald Trump’s Fiscal Year 2026 budget blueprint released Friday calls for major cuts and shakeups at the U.S. Department [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A major national 340B provider advocacy group this week cautioned that proposed 340B reforms stemming from a high-profile GOP U.S. [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The U.S. Supreme Court on Tuesday sided against more than 200 hospitals in a dispute over Medicare disproportionate share hospital [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A federal judge today in Washington, D.C. scrutinized arguments from both manufacturers and the government in a closely watched hearing [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A federal judge in Washington, D.C., is holding high-stakes hearings today on five drug industry lawsuits challenging the government’s opposition [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Recent Health Resources and Services Administration (HRSA) audits found that two drugmakers overcharged covered entities for their 340B drugs, fueling [...] …